Navigation Links
DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership
Date:10/23/2008

Market-Driven Science Facility Opens at Company’s Global R&D Headquarters in Wilmington.

Wilmington, DE (Vocus) October 23, 2008 -– DuPont and Delaware government leaders today unveiled their $80 million Innovation Center partnership, the latest program in strengthening market-driven science and technology capabilities in Delaware. The partnership includes opening of the DuPont Innovation Center business incubator at the company’s global research and development facility here, donating 250 DuPont patents to the Delaware Economic Development Office (DEDO), and delivering 24 biotechnology seminars for Delaware high school teachers and students.

The DuPont Innovation Center partnership has helped science and technology to grow in Delaware. Since its inception, the partnership has resulted in the training and education of more than 800 teachers and students in new developments in the field of biotechnology. Two of the patents donated to the DEDO Intellectual Property Business Creation Program have been used to create Streamline Industries, a new Delaware company that will produce eco-friendly automotive coatings and finishes. DuPont has added 250 employees at the Experimental Station, the company’s largest global research and development center, since the partnership was created in 2005.

“DuPont innovations are transforming global markets faster than ever before in our 206-year history,” said DuPont Chairman and CEO Charles O. Holliday, Jr. “We are thankful to have a partner like the state of Delaware, which values the power o
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
2. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
3. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
4. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
5. Neogen Acquires Product Line From DuPont Animal Health Solutions
6. DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy
7. DuPont Expands Animal Health Solutions Business in Asia
8. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
9. DuPont Strengthens Commitment to Responsible Science with New Biotech Advisory Panel Members
10. DuPont Partnering with China to Increase Farm Productivity
11. DuPont Reports First Quarter Earnings Growth of Over 20 Percent

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership
DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/6/2009)...nda for Arrowhead’s 2010 Personalized Medici...lace on February 22-24, 2010 in Philadelphia, has ...ll highlight key issues in forming partnerships an...ces. , Minneapolis, MN (P...’s 2010 Personalized Medicine Partnerships ...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009)...RNewswire/ -- DSM Pharmaceutical Products today an...with Galenix, Saint Jean D,Illac, France, where DS...ring partner for Galenix commercial products on a ...te on business development opportunities co-market...he strength of Galenix in drug product development...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...-Aldrich (Nasdaq: SIAL ), has released its new "...g. The catalog features more than 4,000 products ...onics, Metal & Ceramic Science,Nanomaterials, ...hapter,contains technical information and highligh...s. , "This catalog serves as a materials sup...
...Inc. (Nasdaq: CEPH ) and Eurand, Inc. (Nasdaq: ...suit in U.S. District Court in Delaware against My...n, Inc., and Barr,Pharmaceuticals, Inc. and its su...t of Eurand,s U.S. Patent Number 7,387,793. This ...ning the muscle relaxant cyclobenzaprine,including...
...l Center,has earned the Joint Commission,s Gold Se...ith the Joint Commission,s national standards for ...dical Center has been awarded its full,accreditati...nounced, initial on-site evaluation,of Shasta Regi...th, 2008.,Following a rigorous survey, the Joint C...
Other Biology Technology:Aldrich(R) Releases Materials Science Catalog That Includes Products to Advance Sustainable Energy and Nanotechnology Research 2Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 2Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 3Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 4Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 5Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission 2Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission 3
(Date:11/4/2009)...s out, hold the power to help militaries and munit...p toxic waste on test sites. , Compounds known a... in World War II and have been used in military mu...are often used to propel tank shells and act like ...reased knowledge of their environmentally harmful ...
(Date:11/4/2009)...s received more than $10 million in research grant...l stimulus program, bringing thetotal amount of st...illion. Thirty-three projects achieved stimulus f...ther. , "The university has thoughtfully underta...larly excellence to federal agency priorities. Th...
(Date:11/4/2009)...FirstCall/ -- Quest Diagnostics Incorporated (NYSE...ic testing, information and services, announced th... income from continuing operations rose to $192 mi...on, or $0.81 per diluted share, for the third quar...educed by a $0.03 per share charge associated with...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Octapharma Group and Fresenius Kabi Enter Into an Exclusive License Development and Supply Agreement for a HESylated Recombinant Protein 5787 1Octapharma Group and Fresenius Kabi Enter Into an Exclusive License Development and Supply Agreement for a HESylated Recombinant Protein 5787 2Octapharma Group and Fresenius Kabi Enter Into an Exclusive License Development and Supply Agreement for a HESylated Recombinant Protein 5787 3INFORMS presents 11 new Fellows Awards 60247 1INFORMS presents 11 new Fellows Awards 60247 2EPAs new green parking lot allows scientists to study permeable surfaces that may help the environment 10560 1EPAs new green parking lot allows scientists to study permeable surfaces that may help the environment 10560 2
...e-eclampsia in the early stages is being trialed i...try & Industry, the magazine of the SCI. The t...low mums-to-be to check for themselves whether the...omless in the early stages but kills 1000 babies i...re reliable than the traditional blood pressure an...
...ologists have put out a call for teeth tusks, femu... left by massive Ice Age floods in southeastern Wa...tons of Mammathus columbi, the Columbian mammoth, ...e Yakima, Columbia and Walla Walla valleys in sout... came to rest as water receded from the temporary ...
...nia, San Diego (UCSD) School of Medicine have deve...cs ?the large-scale study of the structure and fun... them to map an extensive network of the signaling...rk, providing the first comprehensive profile of c... of cell migration in cancer metastasis and inflam...
Other Biology News:Simple home spit test to spot deadly pre-eclampsia 2An ancient bathtub ring of mammoth fossils 2How to steer a moving cell 2How to steer a moving cell 3
Custom Production Service - Quality from AbD Serotec
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
...ptide Synthesis , 20 Amino Acid length max , MS... to customer for future usage conjugation of pepti... 102 days/each , Pre-immune bleed x1 /each , ...t bleed (app. 5 ml) x1 /each , Production blee...
Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
Biology Products: